We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Janssen drugs approved to treat those types of cancers include Imbruvica, in a partnership with AbbVie, to treat certain leukemia and lymphomas, and Darzalex to treat multiple myeloma.